Thalidomide as a Potential Treatment for Scleromyxedema
- 1 March 2004
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 140 (3) , 277-280
- https://doi.org/10.1001/archderm.140.3.277
Abstract
Case Report from JAMA Dermatology — Thalidomide as a Potential Treatment for ScleromyxedemaKeywords
This publication has 29 references indexed in Scilit:
- Fatal scleromyxedema: Report of a case and review of the literatureJournal of the American Academy of Dermatology, 1998
- ScleromyxedemaJournal of the American Academy of Dermatology, 1995
- Improvement of scleromyxedema associated with isotretinoin therapyJournal of the American Academy of Dermatology, 1991
- Scleromyxedema: Therapeutic response to isotretinoin in three patientsJournal of the American Academy of Dermatology, 1988
- PUVA treatment of scleromyxoedemaBritish Journal of Dermatology, 1984
- Lichen Myxedematosus Serum Stimulates Human Skin Fibroblast ProliferationScience, 1978
- Scleromyxedema. A variant of Lichen myxedematosusArchives of Dermatology, 1966
- Autopsy Findings in Lichen MyxedematosusArchives of Dermatology, 1956
- Lichen Myxedematosus (Differentiation from Cutaneous Myxedemas or Mucoid States)Journal of Investigative Dermatology, 1953
- Über eine eigenartige, der Sklerodermie nahestehende AffektionArchives of Dermatological Research, 1908